John Wiley & Sons Inc. logo

John Wiley & Sons Inc. (2F7)

Market Closed
3 Dec, 07:01
XMUN XMUN
31. 40
+0.2
+0.64%
- Market Cap
- P/E Ratio
1.4% Div Yield
0 Volume
2.25 Eps
31.2
Previous Close
Day Range
31.4 31.4
Year Range
29.2 48.8
Want to track 2F7 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 88 days

Summary

2F7 closed Wednesday higher at €31.4, an increase of 0.64% from Tuesday's close, completing a monthly decrease of -1.26% or €0.4. Over the past 12 months, 2F7 stock lost -25.94%.
2F7 pays dividends to its shareholders, with the most recent payment made on Oct 23, 2025. The next estimated payment will be in In 1 month on Jan 23, 2026 for a total of €0.355.
The last earnings report, released on Dec 04, 2025, exceeded the consensus estimates by 0.1%. On average, the company has fell short of earnings expectations by -0.42%, based on the last three reports. The next scheduled earnings report is due on Mar 04, 2026.
John Wiley & Sons Inc. has completed 5 stock splits, with the recent split occurring on Jun 01, 1999.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).

2F7 Chart

John Wiley & Sons, Inc. (WLY) Q2 2026 Earnings Call Transcript

John Wiley & Sons, Inc. (WLY) Q2 2026 Earnings Call Transcript

John Wiley & Sons, Inc. (WLY) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 days ago
John Wiley & Sons, Inc. (WLY) Q1 2026 Earnings Call Transcript

John Wiley & Sons, Inc. (WLY) Q1 2026 Earnings Call Transcript

John Wiley & Sons, Inc. (NYSE:WLY ) Q1 2026 Earnings Call September 4, 2025 10:00 AM EDT Company Participants Brian Campbell - Vice President, Investor Relations Matthew Kissner - President, CEO & Employee Director Craig Albright - Executive VP & CFO James Flynn - Executive VP and GM of Research & Learning Conference Call Participants Dan Moore - CJS Securities, Inc. Presentation Operator Good morning, and welcome to Wiley's First Quarter Fiscal 2026 Earnings Call. As a reminder, this conference is being recorded [Operator Instructions] At this time, I'd like to introduce Wiley's Vice President of Investor Relations, Brian Campbell.

Seekingalpha | 3 months ago
John Wiley & Sons: Strong Absolute Valuation

John Wiley & Sons: Strong Absolute Valuation

While the company will be dealing with some revenue pressures in Q1, including from the high margin AI-licensing revenues, the multiples are compressed. The business has important recurring characteristics and decent leading indicators in the ex-AI businesses. We also like the company's capital allocation and return policies that could lever decent returns for shareholders from these sold-off levels.

Seekingalpha | 4 months ago

John Wiley & Sons Inc. (2F7) FAQ

What is the stock price today?

The current price is €31.40.

On which exchange is it traded?

John Wiley & Sons Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is 2F7.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.4%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Mar 04, 2026.

Has John Wiley & Sons Inc. ever had a stock split?

John Wiley & Sons Inc. had 5 splits and the recent split was on Jun 01, 1999.

John Wiley & Sons Inc. Profile

- Industry
- Sector
Matthew S. Kissner CEO
XMUN Exchange
US9682232064 ISIN
US Country
6,400 Employees
7 Oct 2025 Last Dividend
1 Jun 1999 Last Split
1 Apr 2022 IPO Date

Overview

John Wiley & Sons, Inc., a global research and education company, has been nurturing the world's intellectual and professional communities since 1807. Based in Hoboken, New Jersey, the company thrives through its three operational segments: Research, Academic, and Talent. Serving a diverse array of individuals and organizations—ranging from learned societies and individual researchers to academic, corporate, and government libraries—John Wiley & Sons is recognized for providing scientific, technical, medical, and scholarly journals along with a suite of related content and services. These offerings underscore the company's commitment to supporting the dissemination of knowledge and research across various fields.

Products and Services

John Wiley & Sons, Inc. distinguishes itself by offering a broad spectrum of products and services tailored to meet the needs of the scientific, professional, and educational communities it serves:

  • Scientific, Technical, Medical, and Scholarly Journals: Covering disciplines such as physical sciences and engineering, health sciences, social sciences, and humanities and life sciences, these journals are pivotal in disseminating cutting-edge research to the global scientific community.
  • Literatum Platform: A sophisticated publishing software and service that assists scholarly and professional societies and publishers to effectively deliver, host, enhance, market, and manage their content online, maximizing reach and engagement.
  • Books and Digital Courseware: Ranging from scientific, professional, and education-focused print and digital books to digital courseware, these resources cater to the needs of libraries, corporations, students, professionals, and researchers, facilitating learning and professional development.
  • Test Preparation Services: Offering comprehensive test preparation materials and services that support students and professionals in achieving their academic and career goals.
  • Talent Development Solutions: Dedicated to the professional growth of individuals and organizational success, these services include talent development programs, assessments, and corporate learning solutions designed to cultivate essential skills and competencies.
  • Distribution Channels: John Wiley & Sons leverages a wide array of distribution networks including research libraries, library consortia, independent subscription agents, professional society memberships, bookstores, online booksellers, and direct consumer sales to ensure their products are accessible to a broad audience.

Contact Information

Address: 111 River Street
Phone: 201 748 6000